Investor · Brisbane, CA

Kathryn E. Falberg

Open Kathryn in the network graph →

Filings

4

SEC Form D

Connections

33

co-filers

Capital

$530.0M

across filings

Active

Oct 2009

to Oct 2020

Most-connected co-filers (33)

Douglas T. Sheehy · Brisbane, CA2 shared Stacey D. Seltzer · New York, NY2 shared Mary M. Rozenman · Brisbane, CA2 shared Gregory E. Behar · Brisbane, CA2 shared Susan E. Barrowcliffe · Brisbane, CA2 shared Daniel C. Adelman · Brisbane, CA2 shared Eric J. Bjerkholt · South San Francisco, CA2 shared Mark Mcdade · Boston, MA2 shared Mark J. Iwicki · Arlington, MA2 shared Patrick P. Enright · Menlo Park, CA2 shared Brett K. Haumann · Brisbane, CA1 shared Jeffrey H. Knapp · Brisbane, CA1 shared Robert Bazemore · Fremont, CA1 shared Ted W. Love · South San Francisco, CA1 shared Stephen G. Dilly, Jr · San Mateo, CA1 shared Jean-Francois Formela · Cambridge, MA1 shared Christopher D. Ozeroff · Westminster, CO1 shared Linda S. Grais · Westminster, CO1 shared Michael R. Bristow · Westminster, CO1 shared John L. Zabriskie · Boulder, CO1 shared Mary K. Pendergast · Newton, MA1 shared Burton E. Sobel · Broomfield, CO1 shared Kim Blickenstaff · San Diego, CA1 shared Richard B. Brewer · Broomfield, CO1 shared

Recent filings (4)

Nuvation Bio Inc.Oct 2020 · 16 co-filers$275.3M Nuvation Bio Inc.Oct 2020 · 16 co-filers$275.3M Aimmune Therapeutics, Inc.Nov 2018 · 25 co-filers$98.0M Aimmune Therapeutics, Inc.Nov 2018 · 25 co-filers$98.0M Aimmune Therapeutics, Inc.Mar 2018 · 25 co-filers$156.7M Aimmune Therapeutics, Inc.Mar 2018 · 25 co-filers$156.7M ARCA biopharma, Inc.Oct 2009 · 16 co-filers$500K ARCA biopharma, Inc.Oct 2009 · 16 co-filers$500K

Derived from public SEC Form D (Reg D) filings; entities resolved probabilistically. See Kathryn in the interactive graph →